Neuren Pharmaceuticals Limited (ASX:NEU)
Australia
· Delayed Price · Currency is AUD
19.75
0.00 (0.00%)
At close: Dec 8, 2025
Neuren Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | 149.06 | 142.04 | 157.08 | 0.18 | -7.79 | -9.19 | |
| Depreciation & Amortization | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Loss (Gain) From Sale of Investments | 0.96 | -3.59 | 1.53 | 0.7 | - | - | |
| Stock-Based Compensation | 0.98 | 1.23 | 2.93 | 1.99 | 0.84 | 0.39 | |
| Other Operating Activities | 5.26 | 10.44 | 0.14 | 0.18 | -0.4 | 0.72 | |
| Change in Accounts Receivable | -6.13 | -157.59 | -13.11 | 0.19 | -2.51 | -0.2 | |
| Change in Accounts Payable | 2.71 | - | - | 0.34 | -0.11 | 0.19 | |
| Change in Income Taxes | -15.28 | -3.83 | 36.35 | - | - | - | |
| Operating Cash Flow | 137.57 | -11.27 | 184.93 | 3.6 | -9.97 | -8.08 | |
| Operating Cash Flow Growth | 15.11% | - | 5038.23% | - | - | - | |
| Capital Expenditures | -0.01 | -0.01 | -0.04 | -0.02 | -0.01 | -0.01 | |
| Investment in Securities | -82.27 | 4.14 | -211.45 | - | - | - | |
| Investing Cash Flow | -82.28 | 4.13 | -211.49 | -0.02 | -0.01 | -0.01 | |
| Issuance of Common Stock | 1.38 | 1.66 | 3.64 | - | 23.28 | 20.22 | |
| Repurchase of Common Stock | -50 | -10.43 | - | - | - | - | |
| Other Financing Activities | -0.02 | -0.01 | -0.02 | -0 | -1.11 | -1.08 | |
| Financing Cash Flow | -48.63 | -8.78 | 3.62 | -0 | 22.18 | 19.14 | |
| Foreign Exchange Rate Adjustments | -3.32 | 1.97 | -0.15 | -0.18 | 0.4 | -0.71 | |
| Net Cash Flow | 3.34 | -13.94 | -23.09 | 3.4 | 12.6 | 10.34 | |
| Free Cash Flow | 137.56 | -11.28 | 184.89 | 3.58 | -9.98 | -8.08 | |
| Free Cash Flow Growth | 15.13% | - | 5064.39% | - | - | - | |
| Free Cash Flow Margin | 62.85% | -5.20% | 79.71% | 23.22% | -312.17% | -1127.48% | |
| Free Cash Flow Per Share | 1.06 | -0.09 | 1.41 | 0.03 | -0.08 | -0.08 | |
| Cash Income Tax Paid | 50.03 | 37.22 | -0.88 | -1.39 | -2.52 | -0.49 | |
| Levered Free Cash Flow | 109.15 | -42.25 | 152.97 | 2.59 | -6.76 | -5.12 | |
| Unlevered Free Cash Flow | 109.15 | -42.25 | 152.97 | 2.59 | -6.76 | -5.12 | |
| Change in Working Capital | -18.7 | -161.42 | 23.24 | 0.53 | -2.62 | -0.01 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.